July 21, 2025

Stanford Physician-Scientist Takes CDER Helm

Stanford's George Tidmarsh appointed FDA's new CDER director, bringing 30+ years biotechnology experience and seven approved drugs.

Conexiant

July 17, 2025

Vapes Outperform Nicotine Replacement Therapy in Cessation Trial

Researchers found vaporized nicotine products more effective than nicotine replacement therapy for smoking cessation among socioeconomically disadvantaged adults.

Conexiant

July 17, 2025

Nirsevimab Shows 83% Efficacy Over 6 Months

A large clinical trial in Europe showed that a single dose of nirsevimab reduced infant hospitalizations for RSV-associated lower respiratory tract infections by over 80% over a six-month period.

Conexiant

July 16, 2025

New Guidelines Target Preventive Gaps in Inflammatory Bowel Disease

New clinical recommendations detail updated vaccination and screening protocols to reduce infection and cancer risks in adults with inflammatory bowel disease, particularly those on immune-modifying therapies.

Conexiant

July 14, 2025

Potential Links Between Infection and Alzheimer’s Disease

Researchers examine the potential contribution of Chlamydia pneumoniae and SARS-CoV-2 infections to Alzheimer’s disease pathogenesis, focusing on neuroinflammatory mechanisms and genetic factors such as APOEε4.

Conexiant

June 26, 2025

Medical Groups Unite on Vaccine Policy

Major medical associations jointly reaffirm commitment to respiratory virus vaccines amid federal immunization review process changes.

Conexiant

June 23, 2025

Older Adults Lead Vaccine Comeback

Older Americans are embracing vaccines—backed by new research confirming enhanced safety, disease prevention, and even a potential link to reduced dementia risk.

KFF Health News